Pharmafile
Therapeutic areas in focus
Install App?
Pharmafile
magazine.pharmafile.com
This is how the Install App dialog will look like once your App goes live.
News
News articles from Pharmafile - therapy areas in focus
Controversial ALS drug approved by FDA
New but controversial ALS drug, Relyviro, approved by FDA
Dec 1, 2022 News
Merger planned between Bio-Rad and Qiagen
Bio-Rad and Qiagen plan to merge in a deal potentially worth over $10bn
Dec 1, 2022 News
AstraZeneca’s liver cancer treatment gets FDA approval
FDA approves AstraZeneca's liver cancer treatment
Dec 1, 2022 News
Furosemide approved by FDA for patients with chronic heart failure
FDA approves Furosemide to treat patients with chronic heart failure
Dec 1, 2022 News
Cancer vaccine may be available by 2030
New cancer vaccine may be available by 2030
Dec 1, 2022 News
Johnson & Johnson to buy Abiomed for $17bn
Johnson & Johnson is planning to acquire Abiomed for $17bn
Dec 1, 2022 News
Gilead and MacroGenics partner for bispecific antibody development
Gilead Sciences and Macrogenics partner for bispecific antibody development
Dec 1, 2022 News
FDA announces recall of two blood pressure pills over cancer risk
FDA recalls two blood pressure pills due to risk that they may cause cancer
Dec 1, 2022 News
FDA clears GSK’s Boostrix for use in pregnancy
FDA approves GSK's whooping cough vaccine, Boostrix, for use in pregnant patients
Dec 1, 2022 News
Potentially cancer-stopping pill given to first patient
New pill which may halt cancer is given to first patient in a trial
Dec 1, 2022 News
